766728007: Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing ethanolamine derivative and histamine receptor antagonist\Product containing phenyltoloxamine\Product containing paracetamol and phenyltoloxamine\...

\Product containing only paracetamol and phenyltoloxamine (medicinal product)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet

\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet

\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ethanolamine and/or ethanolamine derivative (product)\Product containing ethanolamine derivative and histamine receptor antagonist\Product containing phenyltoloxamine\Product containing paracetamol and phenyltoloxamine\Product containing only paracetamol and phenyltoloxamine (medicinal product)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet
\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ethanolamine and/or ethanolamine derivative (product)\Product containing ethanolamine derivative and histamine receptor antagonist\Product containing phenyltoloxamine\Product containing paracetamol and phenyltoloxamine\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet
\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing paracetamol\Product containing paracetamol and phenyltoloxamine\Product containing only paracetamol and phenyltoloxamine (medicinal product)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet
\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing paracetamol\Product containing paracetamol and phenyltoloxamine\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet
\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing paracetamol\Product containing paracetamol in oral dose form (medicinal product form)\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet
\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing paracetamol\Product containing paracetamol and phenyltoloxamine\Product containing only paracetamol and phenyltoloxamine (medicinal product)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet
\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing paracetamol\Product containing paracetamol and phenyltoloxamine\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet
\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing paracetamol\Product containing paracetamol in oral dose form (medicinal product form)\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet

\Product manufactured as oral dose form\Product containing paracetamol in oral dose form (medicinal product form)\Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)\Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3662412011 Acetaminophen 500 mg and phenyltoloxamine citrate 30 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3662414012 Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3681711012 Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
3681712017 Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has presentation strength numerator value	500	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has basis of strength substance	Paracetamol	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has basis of strength substance	Phenyltoloxamine citrate	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has presentation strength numerator value	30	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has unit of presentation	Tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has precise active ingredient	Phenyltoloxamine citrate	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has precise active ingredient	Paracetamol	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Is a	Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Is a	Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has precise active ingredient	Phenyltoloxamine citrate	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has basis of strength substance	Phenyltoloxamine citrate	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has precise active ingredient	Paracetamol	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	Has basis of strength substance	Paracetamol	true	Inferred relationship	Existential restriction modifier	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3662412011	Acetaminophen 500 mg and phenyltoloxamine citrate 30 mg oral tablet	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3662414012	Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3681711012	Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet	en	Synonym	Inactive	Entire term case insensitive	SNOMED CT core module
3681712017	Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module